Search - tctmd.com

Displaying 301 - 314 of 314

Sort: Relevancy | Date

News Daily News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

Caitlin E. Cox

January 14, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

News Daily News

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

Yael L. Maxwell

January 13, 2020

News Daily News

FDA: Some Stryker Defibrillators Require Fix for Failure to Deliver Shock

Todd Neale

January 13, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

L.A. McKeown

January 09, 2020

News Daily News

Pulmonary Hypertension During Exercise Foretells Later Risk of Adverse CV Outcomes

Caitlin E. Cox

January 07, 2020

News Daily News

Palliative Care Underused Among Acute MI Patients

L.A. McKeown

January 06, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

Presentation CACI 2019

COAPT Three-Year Outcomes from a Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients with Heart Failure and Secondary Mitral Regurgitation

Presenter: Oscar A. Mendiz

November 29, 2019

Presentation Controversies and Advances 2019

How should we really manage functional mitral regurgitation?

Presenter: Michele Hamilton

November 15, 2019

Presentation Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

Presentation LINC 2019

Medical Management Of Pulmonary Embolism

Presenter: James Horowitz

January 25, 2019

Advertisement

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Obesity and Aortic Stenosis: Genetic Analysis Hints at Causal Link

FDA: Some Stryker Defibrillators Require Fix for Failure to Deliver Shock

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Program to Cut Hospital Readmissions Has Not Changed Racial Disparities in Acute MI

Pulmonary Hypertension During Exercise Foretells Later Risk of Adverse CV Outcomes

Palliative Care Underused Among Acute MI Patients

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

The Biggest News of 2019: TCTMD’s Top 10

COAPT Three-Year Outcomes from a Randomized Trial of Transcatheter Mitral Valve Leaflet Approximation in Patients with Heart Failure and Secondary Mitral Regurgitation

How should we really manage functional mitral regurgitation?

Echo imaging in HFpEF

Medical Management Of Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content